Yazidi Meriem, Ezzaouia Khaled, Madhi Wiem, Oueslati Ibtissem, Ouarda Fatma, Murali Sami, Chihaoui Melika
Department of Endocrinology, University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta Hospital, 1007 Tunis, Tunisia.
Department of cardiology, University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta Hospital, 1007 Tunis, Tunisia.
Ann Cardiol Angeiol (Paris). 2023 Apr;72(2):101579. doi: 10.1016/j.ancard.2022.11.014. Epub 2022 Dec 19.
The prevalence and nature of cardiac complications associated with hyperthyroidism vary considerably in the literature depending on the population studied and the means of investigation used to detect them. The aim of this study was to determine the structural, functional, and rhythmic cardiac abnormalities associated with hyperthyroidism and to identify their risk factors.
It is a cross-sectional study conducted in thirty adult patients with overt or subclinical hyperthyroidism. Each patient underwent a clinical cardiovascular examination, a cardiac Doppler ultrasound, a pulmonary ultrasound and a 24-hours rhythm holter. The diagnosis of cardiothyreosis (thyrotoxic heart disease) was retained if an arrhythmia, heart failure (HF) and/or pulmonary arterial hypertension (PAH) were noted following the investigations carried out.
The mean age of the patients was 44.8 ± 14.4 years. The sex ratio (M/F) was 0.3. Five patients (17%) had subclinical hyperthyroidism and 25 (83%) had overt hyperthyroidism. Thirteen patients (43%) had cardiothyreosis. It consisted of a rhythm disorder in three patients (10%), PAH in twelve patients (40%) and HF in eight patients (27%). An age over 50 years and toxic nodular etiology were associated with atrial fibrillation (AF), p = 0.041 and p = 0.004 respectively. Tachycardia and a higher number of atrial extrasystoles were associated with HF, p = 0.039 and p = 0.007 respectively. A lower TSH, tachycardia and a higher number of atrial extrasystoles were associated with the presence of PAH, p = 0.004, p = 0.011 and p = 0.007 respectively.
Cardiac complications should be sought in all patients with hyperthyroidism, especially in elderly and tachycardic patients. Specialized investigations such as echocardiography or 24 hours rhythmic holter should be requested in these cases.
根据所研究的人群以及用于检测甲状腺功能亢进相关心脏并发症的调查方法不同,文献中关于这些并发症的患病率和性质差异很大。本研究的目的是确定与甲状腺功能亢进相关的心脏结构、功能和节律异常,并识别其危险因素。
这是一项针对30例显性或亚临床甲状腺功能亢进成年患者的横断面研究。每位患者均接受了临床心血管检查、心脏多普勒超声检查、肺部超声检查以及24小时动态心电图监测。如果在进行的检查中发现心律失常、心力衰竭(HF)和/或肺动脉高压(PAH),则诊断为甲状腺毒症性心脏病(甲状腺毒性心脏病)。
患者的平均年龄为44.8±14.4岁。男女比例(M/F)为0.3。5例患者(17%)患有亚临床甲状腺功能亢进,25例(83%)患有显性甲状腺功能亢进。13例患者(43%)患有甲状腺毒症性心脏病。其中包括3例患者(10%)出现节律紊乱,12例患者(40%)出现PAH,8例患者(27%)出现HF。年龄超过50岁和毒性结节病因分别与心房颤动(AF)相关,p值分别为0.041和0.004。心动过速和较高数量的房性期前收缩分别与HF相关,p值分别为0.039和0.007。较低的促甲状腺激素(TSH)、心动过速和较高数量的房性期前收缩分别与PAH的存在相关,p值分别为0.004、0.011和0.007。
所有甲状腺功能亢进患者均应排查心脏并发症,尤其是老年和心动过速患者。在这些情况下,应要求进行超声心动图或24小时动态心电图等专业检查。